Betaseron Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction
Condition:   Multiple Sclerosis, Relapsing-RemittingInterventions:   Drug: Interferon beta-1b (Betaseron, BAY86-5046);   Device: BETACONNECT deviceSponsor:   BayerNot yet recruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2016 Category: Research Source Type: clinical trials